(RELX) Relx - Overview
Sector: Industrials | Industry: Specialty Business Services | Exchange: NYSE (USA) | Market Cap: 59.623m USD | Total Return: -31% in 12m
Information, Analytics, Data, Tools, Software
Total Rating 45
Safety 72
Buy Signal -0.57
Specialty Business Services
Industry Rotation: -7.2
Industry Rotation: -7.2
Market Cap:
59.6B
Avg Turnover: 102M USD
Avg Turnover: 102M USD
ATR:
2.77%
Peers RS (IBD): 20.4
Peers RS (IBD): 20.4
Risk 5d forecast
Volatility21.3%
Rel. Tail Risk2.15%
Reward TTM
Sharpe Ratio-1.28
Alpha-47.42
Character TTM
Beta0.522
Beta Downside0.375
Drawdowns 3y
Max DD49.91%
CAGR/Max DD0.05
Warnings
Altman Z'' 1.09 < 1.0 - financial distress zone
Tailwinds
No distinct edge detected
Description: RELX Relx
RELX PLC provides information-based analytics and decision tools across four segments: Risk, Scientific, Technical & Medical, Legal, and Exhibitions. This business model is common in the information services sector, which typically involves high intellectual property value and recurring revenue streams.
The Risk segment focuses on analytics for risk evaluation and prediction, including commercial healthcare. The Scientific, Technical & Medical segment supplies scientific and medical information and datasets. The Legal segment provides legal, regulatory, and business information and analytics, a core component of legal tech. The Exhibitions segment facilitates connections and transactions through digital tools and in-person events, a strategy increasingly adopted by event organizers to enhance engagement.
RELX PLC was incorporated in 1903 and is headquartered in London, United Kingdom. To learn more about RELX PLCs financial performance and market position, consider exploring its detailed reports on ValueRay.
- Subscription revenue growth in analytics tools
- Data and content acquisition costs impact margins
- Regulatory scrutiny on data privacy increases compliance burden
- Global economic slowdown reduces exhibition attendance
- Healthcare and legal sector demand drives analytics tool adoption
Piotroski VR‑10 (Strict)
8.0
| Net Income: 3.99b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.37 > 0.02 and ΔFCF/TA 16.54 > 1.0 |
| NWC/Revenue: -15.94% < 20% (prev -18.93%; Δ 2.99% < -1%) |
| CFO/TA 0.37 > 3% & CFO 5.51b > Net Income 3.99b |
| Net Debt (7.19b) to EBITDA (6.07b): 1.18 < 3 |
| Current Ratio: 0.49 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.83b) vs 12m ago -3.31% < -2% |
| Gross Margin: 65.00% > 18% (prev 0.62%; Δ 6.44k% > 0.5%) |
| Asset Turnover: 128.1% > 50% (prev 92.14%; Δ 35.99% > 0%) |
| Interest Coverage Ratio: 7.71 > 6 (EBITDA TTM 6.07b / Interest Expense TTM 568.5m) |
Altman Z''
1.09
| A: -0.21 (Total Current Assets 2.95b - Total Current Liabilities 5.98b) / Total Assets 14.73b |
| B: 0.13 (Retained Earnings 1.89b / Total Assets 14.73b) |
| C: 0.30 (EBIT TTM 4.38b / Avg Total Assets 14.82b) |
| D: 0.03 (Book Value of Equity 392.3m / Total Liabilities 12.35b) |
| Altman-Z'' Score: 1.09 = BB |
Beneish M
-3.10
| DSRI: 0.77 (Receivables 2.46b/2.32b, Revenue 18.99b/13.74b) |
| GMI: 0.95 (GM 65.00% / 61.53%) |
| AQI: 0.99 (AQ_t 0.79 / AQ_t-1 0.79) |
| SGI: 1.38 (Revenue 18.99b / 13.74b) |
| TATA: -0.10 (NI 3.99b - CFO 5.51b) / TA 14.73b) |
| Beneish M-Score: -3.10 (Cap -4..+1) = AA |
What is the price of RELX shares?
As of April 11, 2026, the stock is trading at USD 33.30 with a total of 2,922,032 shares traded.
Over the past week, the price has changed by -0.92%, over one month by -5.37%, over three months by -22.14% and over the past year by -30.99%.
Over the past week, the price has changed by -0.92%, over one month by -5.37%, over three months by -22.14% and over the past year by -30.99%.
Is RELX a buy, sell or hold?
Relx has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy RELX.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RELX price?
| Analysts Target Price | 52.1 | 56.5% |
Relx (RELX) - Fundamental Data Overview
as of 11 April 2026
Market Cap GBP = 44.41b (59.62b USD * 0.7448 USD.GBP)P/E Trailing = 22.2267
P/E Forward = 17.7305
P/S = 6.2172
P/B = 19.1716
P/EG = 1.3644
Revenue TTM = 18.99b GBP
EBIT TTM = 4.38b GBP
EBITDA TTM = 6.07b GBP
Long Term Debt = 5.63b GBP (from longTermDebt, last quarter)
Short Term Debt = 1.57b GBP (from shortTermDebt, last quarter)
Debt = 7.32b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.19b GBP (from netDebt column, last quarter)
Enterprise Value = 51.60b GBP (44.41b + Debt 7.32b - CCE 130.8m)
Interest Coverage Ratio = 7.71 (Ebit TTM 4.38b / Interest Expense TTM 568.5m)
EV/FCF = 9.43x (Enterprise Value 51.60b / FCF TTM 5.47b)
FCF Yield = 10.60% (FCF TTM 5.47b / Enterprise Value 51.60b)
FCF Margin = 28.80% (FCF TTM 5.47b / Revenue TTM 18.99b)
Net Margin = 21.02% (Net Income TTM 3.99b / Revenue TTM 18.99b)
Gross Margin = 65.00% ((Revenue TTM 18.99b - Cost of Revenue TTM 6.65b) / Revenue TTM)
Gross Margin QoQ = 63.75% (prev 66.25%)
Tobins Q-Ratio = 3.50 (Enterprise Value 51.60b / Total Assets 14.73b)
Interest Expense / Debt = 1.07% (Interest Expense 78.5m / Debt 7.32b)
Taxrate = 25.09% (365.7m / 1.46b)
NOPAT = 3.28b (EBIT 4.38b * (1 - 25.09%))
Current Ratio = 0.49 (Total Current Assets 2.95b / Total Current Liabilities 5.98b)
Debt / Equity = 3.10 (Debt 7.32b / totalStockholderEquity, last quarter 2.36b)
Debt / EBITDA = 1.18 (Net Debt 7.19b / EBITDA 6.07b)
Debt / FCF = 1.31 (Net Debt 7.19b / FCF TTM 5.47b)
Total Stockholder Equity = 2.81b (last 4 quarters mean from totalStockholderEquity)
RoA = 26.93% (Net Income 3.99b / Total Assets 14.73b)
RoE = 142.1% (Net Income TTM 3.99b / Total Stockholder Equity 2.81b)
RoCE = 51.92% (EBIT 4.38b / Capital Employed (Equity 2.81b + L.T.Debt 5.63b))
RoIC = 33.55% (NOPAT 3.28b / Invested Capital 9.78b)
WACC = 6.83% (E(44.41b)/V(51.73b) * Re(7.82%) + D(7.32b)/V(51.73b) * Rd(1.07%) * (1-Tc(0.25)))
Discount Rate = 7.82% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -100.0 | Cagr: -1.67%
[DCF] Terminal Value 85.53% ; FCFF base≈4.51b ; Y1≈5.57b ; Y5≈9.49b
[DCF] Fair Price = 116.1 (EV 214.76b - Net Debt 7.19b = Equity 207.57b / Shares 1.79b; r=6.83% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 28.41 | EPS CAGR: 0.0% | SUE: 0.0 | # QB: 0
Revenue Correlation: 94.04 | Revenue CAGR: 16.86% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=1.93 | Chg7d=-0.003 | Chg30d=-0.034 | Revisions Net=-3 | Growth EPS=+10.6% | Growth Revenue=+6.1%
EPS next Year (2027-12-31): EPS=2.17 | Chg7d=-0.027 | Chg30d=+0.083 | Revisions Net=+2 | Growth EPS=+12.8% | Growth Revenue=+6.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 3 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 3.4% (Discount Rate 7.9% - Earnings Yield 4.5%)
[Growth] Growth Spread = +2.8% (Analyst 6.2% - Implied 3.4%)
External Resources